These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 35409057)

  • 21. Review: Effect of Gut Microbiota and Its Metabolite SCFAs on Radiation-Induced Intestinal Injury.
    Li Y; Zhang Y; Wei K; He J; Ding N; Hua J; Zhou T; Niu F; Zhou G; Shi T; Zhang L; Liu Y
    Front Cell Infect Microbiol; 2021; 11():577236. PubMed ID: 34307184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Analysis of Hypertension-Associated Intestinal Microbiota.
    Dan X; Mushi Z; Baili W; Han L; Enqi W; Huanhu Z; Shuchun L
    Int J Med Sci; 2019; 16(6):872-881. PubMed ID: 31337961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut Microbiome over a Lifetime and the Association with Hypertension.
    Yano Y; Niiranen TJ
    Curr Hypertens Rep; 2021 Mar; 23(3):15. PubMed ID: 33686539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut microbiota in kidney disease and hypertension.
    Antza C; Stabouli S; Kotsis V
    Pharmacol Res; 2018 Apr; 130():198-203. PubMed ID: 29496593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut Microbiota Promote Angiotensin II-Induced Arterial Hypertension and Vascular Dysfunction.
    Karbach SH; Schönfelder T; Brandão I; Wilms E; Hörmann N; Jäckel S; Schüler R; Finger S; Knorr M; Lagrange J; Brandt M; Waisman A; Kossmann S; Schäfer K; Münzel T; Reinhardt C; Wenzel P
    J Am Heart Assoc; 2016 Aug; 5(9):. PubMed ID: 27577581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations of the Gut Microbiome in Hypertension.
    Yan Q; Gu Y; Li X; Yang W; Jia L; Chen C; Han X; Huang Y; Zhao L; Li P; Fang Z; Zhou J; Guan X; Ding Y; Wang S; Khan M; Xin Y; Li S; Ma Y
    Front Cell Infect Microbiol; 2017; 7():381. PubMed ID: 28884091
    [No Abstract]   [Full Text] [Related]  

  • 27. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
    Arab JP; Martin-Mateos RM; Shah VH
    Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential mechanisms linking gut microbiota and portal hypertension.
    Baffy G
    Liver Int; 2019 Apr; 39(4):598-609. PubMed ID: 30312513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obstructive Sleep Apnea-Induced Hypertension: Role of the Gut Microbiota.
    Durgan DJ
    Curr Hypertens Rep; 2017 Apr; 19(4):35. PubMed ID: 28365886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Arguments for a role of the gut microbiota in the pathophysiology of hypertension].
    Huart J; Krzesinski JM; Jouret F
    Rev Med Liege; 2020 Sep; 75(9):588-592. PubMed ID: 32909410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered gut microbiota in Rett syndrome.
    Strati F; Cavalieri D; Albanese D; De Felice C; Donati C; Hayek J; Jousson O; Leoncini S; Pindo M; Renzi D; Rizzetto L; Stefanini I; Calabrò A; De Filippo C
    Microbiome; 2016 Jul; 4(1):41. PubMed ID: 27473171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.
    Kanbay M; Onal EM; Afsar B; Dagel T; Yerlikaya A; Covic A; Vaziri ND
    Int Urol Nephrol; 2018 Aug; 50(8):1453-1466. PubMed ID: 29728993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiota contributes to the development of hypertension in a genetic mouse model of systemic lupus erythematosus.
    de la Visitación N; Robles-Vera I; Toral M; Gómez-Guzmán M; Sánchez M; Moleón J; González-Correa C; Martín-Morales N; O'Valle F; Jiménez R; Romero M; Duarte J
    Br J Pharmacol; 2021 Sep; 178(18):3708-3729. PubMed ID: 33931880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestinal Dysbiosis in Carriers of Carbapenem-Resistant
    Korach-Rechtman H; Hreish M; Fried C; Gerassy-Vainberg S; Azzam ZS; Kashi Y; Berger G
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32350099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
    Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
    Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of Alterations in the Gut Microbiota and Intestinal Permeability in Patients With Hashimoto Thyroiditis.
    Cayres LCF; de Salis LVV; Rodrigues GSP; Lengert AVH; Biondi APC; Sargentini LDB; Brisotti JL; Gomes E; de Oliveira GLV
    Front Immunol; 2021; 12():579140. PubMed ID: 33746942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut microbiome of a porcine model of metabolic syndrome and HF-pEF.
    O'Donovan AN; Herisson FM; Fouhy F; Ryan PM; Whelan D; Johnson CN; Cluzel G; Ross RP; Stanton C; Caplice NM
    Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H590-H603. PubMed ID: 32031871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.
    Rodríguez C; Romero E; Garrido-Sanchez L; Alcaín-Martínez G; Andrade RJ; Taminiau B; Daube G; García-Fuentes E
    Gut Microbes; 2020 Nov; 12(1):1725220. PubMed ID: 32129694
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut microbiota in hypertension.
    Jose PA; Raj D
    Curr Opin Nephrol Hypertens; 2015 Sep; 24(5):403-9. PubMed ID: 26125644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut Microbiome and Metabolites in Systemic Lupus Erythematosus: Link, Mechanisms and Intervention.
    Zhang L; Qing P; Yang H; Wu Y; Liu Y; Luo Y
    Front Immunol; 2021; 12():686501. PubMed ID: 34335588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.